anti-CD66b (human), mAb (ANC4A4) (preservative free)
| Code | Size | Price |
|---|
| ANC-220-820-100ug | 100 ug | £243.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Mouse IgG1kappa
Antibody Clonality: Monoclonal
Antibody Clone: ANC4A4
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Fluorescence-activated cell sorting (FACS)
Shipping:
BI
Storage:
+4°C
Documents
Further Information
Alternate Names/Synonyms:
CEACAM8; Carcinoembryonic Antigen-related Cell Adhesion Molecule 8
Concentration:
1mg/ml
EClass:
32160000
Form (Short):
liquid
Formulation:
50mM Sodium Phosphate pH 7.5, 100mM Potassium Chloride, 150mM NaCl.
Handling Advice:
Avoid freeze/thaw cycles.Keep sterile.
Immunogen:
Recombinant soluble human CD66b.
Labels - Conjugates:
Preservative Free
Long Description:
Monoclonal Antibody. Binds to CD66b on the cell surface of human PMN in flow cytometry and works as an EIA capture reagent for recombinant human CD66b utilizing either clone ANC1D5 (Cat #ANC-217-030) or ANC3C5 (Cat# ANC-219-030) as a detection reagent. Applications: ELISA, FACS. Isotype: Mouse IgG1kappa. Clone: ANC4A4. Liquid. 50mM Sodium Phosphate pH 7.5, 100mM Potassium Chloride, 150mM NaCl. Human CD66b (CEACAM8, CGMb, NCA-95, CD67) is a 95kD member of the Carcinoembryonic Antigen (CEA) group. It is expressed on granulocytes and functions as an adhesion molecule. Similar to the CD66 a, c, and d isoforms, engagement of CD66b on neutrophils causes increased adhesion to endothelial cells. Crosslinking CD66b on neutrophils with antibodies triggers IL-8 release.
NCBI, Uniprot Number:
P31997
Package Type:
Plastic Vial
Product Description:
Human CD66b (CEACAM8, CGMb, NCA-95, CD67) is a 95kD member of the Carcinoembryonic Antigen (CEA) group. It is expressed on granulocytes and functions as an adhesion molecule. Similar to the CD66 a, c, and d isoforms, engagement of CD66b on neutrophils causes increased adhesion to endothelial cells. Crosslinking CD66b on neutrophils with antibodies triggers IL-8 release.
Purity:
>95% (SDS-PAGE)
Source / Host:
Purified from concentrated hybridoma tissue culture supernatant.
Specificity:
Binds to CD66b on the cell surface of human PMN in flow cytometry and works as an EIA capture reagent for recombinant human CD66b utilizing either clone ANC1D5 (Cat #ANC-217-030) or ANC3C5 (Cat# ANC-219-030) as a detection reagent.
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.
Related Products
| Product Name | Product Code | Supplier | anti-CD66b (human), mAb (ANC1D5) | ANC-217-020 | Ancell | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| anti-CD66b (human), mAb (ANC1D5) (Biotin) | ANC-217-030 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC1D5) (FITC) | ANC-217-040 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC3C5) | ANC-219-020 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC3C5) (Biotin) | ANC-219-030 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC3C5) (FITC) | ANC-219-040 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC4A4) | ANC-220-020 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC4A4) (Biotin) | ANC-220-030 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-CD66b (human), mAb (ANC4A4) (FITC) | ANC-220-040 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||